[1]
Pradip Kumar Sarma, Sukumar Mukherjee, R N Sarkar, Santosh Kumar Mandal, Pradeepta Patra, Tanoy Bose, Ajit Surin, Santa Naorem, Kaushik Basu, J.R. Parida and CT Arunachalam 2022. A Multi-centre Study to Evaluate the Long-Term Efficacy and Safety of Biosimilar Infliximab (Infimabâ„¢) in Ankylosing Spondylitis in Real-world Clinical Settings - A perspective from Eastern India. International Journal of Medical Research and Review. 10, 4 (Aug. 2022), 113-121.